Real‐world data of atezolizumab plus carboplatin and etoposide in elderly patients with extensive‐disease small‐cell lung cancer

Author:

Shiono Ayako1,Imai Hisao12ORCID,Wasamoto Satoshi3,Tsuda Takeshi4,Nagai Yoshiaki5,Minemura Hiroyuki6ORCID,Yamada Yutaka7ORCID,Kishikawa Takayuki8,Umeda Yukihiro9,Takechi Hiroki3,Yamaguchi Ou1,Mouri Atsuto1,Kaira Kyoichi1ORCID,Taniguchi Hirokazu4ORCID,Minato Koichi2,Kagamu Hiroshi1

Affiliation:

1. Department of Respiratory Medicine, International Medical Center Saitama Medical University Hidaka Japan

2. Division of Respiratory Medicine Gunma Prefectural Cancer Center Ota Japan

3. Division of Respiratory Medicine Saku Central Hospital Advanced Care Center Saku Japan

4. Division of Respiratory Medicine Toyama Prefectural Central Hospital Toyama Japan

5. Department of Respiratory Medicine Jichi Medical University, Saitama Medical Center Saitama Japan

6. Department of Pulmonary Medicine Fukushima Medical University Fukushima Japan

7. Division of Respiratory Medicine Ibaraki Prefectural Central Hospital Kasama Japan

8. Division of Thoracic Oncology Tochigi Cancer Center Utsunomiya Japan

9. Third Department of Internal Medicine, Faculty of Medical Sciences University of Fukui Eiheiji Japan

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3